Carfilzomib Therapy in Pediatric Acute Lymphoblastic Leukemia Overview In this study, the safety and tolerability of a combination of carfilzomib and vincristine, dexamethasone, asparaginase, and daunorubicin (VXLD) were assessed in children with relapsed and/or refractory acute lymphoblastic leukemia (ALL). ALL is the most common cancer diagnosed in childhood and survival for patients
Tag: acute lymphoblastic leukemia
pediatric leukemia patients utilizing levofloxacin
pediatric leukemia patients utilizing levofloxacin STUDY BACKGROUND Bacterial infection-related morbidity and mortality are high in children treated for acute myeloid leukemia (AML) and relapsed acute lymphoblastic leukemia (rALL). Bacteremia not only contributes to mortality but also prolongs hospitalization, delays chemotherapy, decreases the quality of life, and requires the administration of costly and
